ArticleInflammatory bowel diseases2023

Impact of Vedolizumab on Extraintestinal Manifestations in Inflammatory Bowel Disease: Results From a Descriptive, Retrospective, Real-world Study.

Uri Kopylov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.